BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20854473)

  • 1. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
    Cho YJ; Yoon J; Ko YS; Kim SY; Cho SJ; Kim WH; Park JW; Youn HD; Kim JH; Lee BL
    APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer.
    Cho YJ; Kim JH; Yoon J; Cho SJ; Ko YS; Park JW; Lee HS; Lee HE; Kim WH; Lee BL
    BMC Gastroenterol; 2010 Aug; 10():91. PubMed ID: 20704706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear expression of glycogen synthase kinase-3β and lack of membranous β-catenin is correlated with poor survival in colon cancer.
    Salim T; Sjölander A; Sand-Dejmek J
    Int J Cancer; 2013 Aug; 133(4):807-15. PubMed ID: 23389968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
    Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
    Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aurora kinase A regulates GSK-3beta in gastric cancer cells.
    Dar AA; Belkhiri A; El-Rifai W
    Oncogene; 2009 Feb; 28(6):866-75. PubMed ID: 19060929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β.
    Yoon J; Ko YS; Cho SJ; Park J; Choi YS; Choi Y; Pyo JS; Ye SK; Youn HD; Lee JS; Chang MS; Kim MA; Lee BL
    APMIS; 2015 May; 123(5):373-82. PubMed ID: 25846563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
    Cao Q; Feng YJ
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway.
    Zhou Y; Wang Y; Wen J; Zhao H; Dong X; Zhang Z; Wang S; Shen L
    Oncotarget; 2016 Mar; 7(13):16529-41. PubMed ID: 26918728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
    Lamarre M; Desrosiers RR
    Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
    Neelam S; Brooks MM; Cammarata PR
    Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
    Kaga S; Zhan L; Altaf E; Maulik N
    J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of β-catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop.
    Jamieson C; Sharma M; Henderson BR
    Traffic; 2011 Aug; 12(8):983-99. PubMed ID: 21496192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest.
    Wang JS; Wang CL; Wen JF; Wang YJ; Hu YB; Ren HZ
    World J Gastroenterol; 2008 Jul; 14(25):3982-9. PubMed ID: 18609681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells.
    Zhang X; Yin WK; Shi XD; Li Y
    Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
    Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
    J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.